MRE-269 ( MRE-269; MRE269; MRE 269; ACT-333679 )

Catalog No. M17517 CAS No. 475085-57-5

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

MRE-269
Note

Research use only, not for human use.
Brief Description

Ursonic acid belongs to the family of Ursane Triterpenes whose structure is based on the pentacyclic ursane skeleton. It has potential as HIV-1 Protease Inhibitor.
Description

MRE-269, also known as ACT-333679, is a long-acting and highly selective prostacyclin receptor agonist. MRE-269, the active form or metabolite of Selexipag (NS-304), is much more selective for the IP receptor than are the prostacyclin analogs beraprost and iloprost, which also have high affinity for the EP(3) receptor.
Synonyms

MRE-269; MRE269; MRE 269; ACT-333679
Pathway

Others
Target

Other Targets
Recptor

HIV-1 protease
Research Area

Cardiovascular Disease
Indication

——

CAS Number

475085-57-5
Formula Weight

419.52
Molecular Formula

C25H29N3O3
Purity

98%
Solubility

DMSO : ≥ 50 mg/mL. 119.18 mM; H2O : < 0.1 mg/mL
SMILES

CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1C)C)C(=O)O
Chemical Name

2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetic acid